Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P33527 (
ABCC1
)
1,164
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Sphingosine 1-phosphate
(
S1P
), a potent sphingolipid mediator produced by sphingosine kinase isoenzymes (SphK1 and SphK2), regulates diverse cellular processes important for breast cancer progression acting in an autocrine and/or paracrine manner. Here we show that SphK1, but not SphK2, increased
S1P
export from MCF-7 cells. Whereas for both estradiol (E(2)) and epidermal growth factor-activated SphK1 and production of
S1P
, only E(2) stimulated rapid release of
S1P
and dihydro-
S1P
from MCF-7 cells. E(2)-induced
S1P
and dihydro-
S1P
export required estrogen receptor-alpha, not GPR30, and was suppressed either by pharmacological inhibitors or gene silencing of
ABCC1
(multidrug resistant protein 1) or ABCG2 (breast cancer resistance protein). Inhibiting these transporters also blocked E(2)-induced activation of ERK1/2, indicating that E(2) activates ERK via downstream signaling of
S1P
. Taken together, our findings suggest that E(2)-induced export of
S1P
mediated by
ABCC1
and ABCG2 transporters and consequent activation of
S1P
receptors may contribute to nongenomic signaling of E(2) important for breast cancer pathophysiology.
...
PMID:Estradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2. 2011 Mar 55
Sphingosine 1-phosphate
(
S1P
), a bioactive lipid generated by sphingosine kinases (SphK1/2), initiates different signalling pathways involved in physiological and pathological processes. We previously demonstrated that in rat myometrium at late (day 19) gestation, SphK1 increases the expression of COX2 via
S1P
generation and release. In rat uterine leiomyoma cells (ELT3), SphK1/
S1P
axis controls survival and proliferation. In the present study we demonstrate that PDBu activates SphK1 but not SphK2. SphK1 activation requires PKC and MAPK ERK1/2.
S1P
produced by PDBu is released in the medium. PDBu-induced
S1P
export is abolished by Ro-318220 and BIM (PKC inhibitors), by U0126 and PD98059 (MEK inhibitors), SKI-II (SphKI/2 inhibitor) and SphK1-siRNA, suggesting the involvement of PKC, ERK and SphK1 respectively. The release of
S1P
is insensitive to inhibitors of ATP Binding Cassette (ABC)A1 and ABCB1 transporters, but is abolished when
ABCC1
transporters are inhibited by MK571 or down-regulated by
ABCC1
-siRNA. PDBu increases COX2 expression that is blocked by the inhibition of PKC, ERK1/2, SphK1, and when cells are treated with MK571 or transfected with
ABCC1
-siRNA. The induction of COX2 by the
S1P
release due to PDBu or by exogenous
S1P
involves S1P2 receptors coupled to Gi. In myometrium from rat at late gestation, the release of
S1P
is also strongly reduced when SphK and
ABCC1
are inhibited. The data reveal that in rat leiomyoma cells and late pregnant rat myometrium, the release of
S1P
involves a similar signalling pathway and occurs through
ABCC1
.
...
PMID:ATP-binding cassette ABCC1 is involved in the release of sphingosine 1-phosphate from rat uterine leiomyoma ELT3 cells and late pregnant rat myometrium. 2180 51